Cellular interactions in the pathogenesis of interstitial lung diseases

被引:229
作者
Bagnato, Gianluca [1 ]
Harari, Sergio [2 ]
机构
[1] Univ Messina, Azienda Osped Univ Gaetano Martino, Dipartimento Med Clin & Sperimentale, Unita Operativa Reumatol, Messina, Italy
[2] Osped San Giuseppe MultiMed, Serv Fisiopatol Resp Emodinam Polmonare, Unita Operativa Pneumol & Terapia Semi Intensiva, Milan, Italy
关键词
D O I
10.1183/09059180.00003214
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Interstitial lung disease (ILD) encompasses a large and diverse group of pathological conditions that share similar clinical, radiological and pathological manifestations, despite potentially having quite different aetiologies and comorbidities. Idiopathic pulmonary fibrosis (IPF) represents probably the most aggressive form of ILD and systemic sclerosis is a multiorgan fibrotic disease frequently associated with ILD. Although the aetiology of these disorders remains unknown, in this review we analyse the pathogenic mechanisms by cell of interest (fibroblast, fibrocyte, myofibroblast, endothelial and alveolar epithelial cells and immune competent cells). New insights into the complex cellular contributions and interactions will be provided, comparing the role of cell subsets in the pathogenesis of IPF and systemic sclerosis.
引用
收藏
页码:102 / 114
页数:13
相关论文
共 135 条
[1]  
ADLER KB, 1986, AM REV RESPIR DIS, V133, P1043
[2]   Alterations in Lung Mast Cell Populations in Patients with Chronic Obstructive Pulmonary Disease [J].
Andersson, Cecilia K. ;
Mori, Michiko ;
Bjermer, Leif ;
Lofdahl, Claes-Goran ;
Erjefalt, Jonas S. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181 (03) :206-217
[3]   Fibrocytes are a potential source of lung fibroblasts in idiopathic pulmonary fibrosis [J].
Andersson-Sjoland, Annika ;
de Alba, Carolina Garcia ;
Nihlberg, Kristian ;
Becerril, Carina ;
Ramirez, Remedios ;
Pardo, Annie ;
Westergren-Thorsson, Gunilla ;
Selman, Moises .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2008, 40 (10) :2129-2140
[4]   Pericytes: Developmental, Physiological, and Pathological Perspectives, Problems, and Promises [J].
Armulik, Annika ;
Genove, Guillem ;
Betsholtz, Christer .
DEVELOPMENTAL CELL, 2011, 21 (02) :193-215
[5]  
Au Karen, 2009, Curr Rheumatol Rep, V11, P111
[6]   Circulating endothelial progenitor cells in systemic sclerosis: association with disease severity [J].
Avouac, J. ;
Juin, F. ;
Wipff, J. ;
Couraud, P. O. ;
Chiocchia, G. ;
Kahan, A. ;
Boileau, C. ;
Uzan, G. ;
Allanore, Y. .
ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 (10) :1455-1460
[7]   Simvastatin attenuates the development of pulmonary and cutaneous fibrosis in a murine model of systemic sclerosis [J].
Bagnato, Gianluca ;
Bitto, Alessandra ;
Pizzino, Gabriele ;
Irrera, Natasha ;
Sangari, Donatella ;
Cinquegrani, Maurizio ;
Roberts, William Neal ;
Cerinic, Marco Matucci ;
Squadrito, Francesco ;
Altavilla, Domenica ;
Bagnato, Gianfilippo ;
Saitta, Antonino .
RHEUMATOLOGY, 2013, 52 (08) :1377-1386
[8]   The antifibrotic effects of plasminogen activation occur via prostaglandin E2 synthesis in humans and mice [J].
Bauman, Kristy A. ;
Wettlaufer, Scott H. ;
Okunishi, Katsuhide ;
Vannella, Kevin M. ;
Stoolman, Joshua S. ;
Huang, Steven K. ;
Courey, Anthony J. ;
White, Eric S. ;
Hogaboam, Cory M. ;
Simon, Richard H. ;
Toews, Galen B. ;
Sisson, Thomas H. ;
Moore, Bethany B. ;
Peters-Golden, Marc .
JOURNAL OF CLINICAL INVESTIGATION, 2010, 120 (06) :1950-1960
[9]   The role of the Th2CC chemokine ligand CCL17 in pulmonary fibrosis [J].
Belperio, JA ;
Dy, M ;
Murray, L ;
Burdick, MD ;
Xue, YY ;
Strieter, RM ;
Keane, MP .
JOURNAL OF IMMUNOLOGY, 2004, 173 (07) :4692-4698
[10]   Cytokine profiles in idiopathic pulmonary fibrosis suggest an important role for TGF-β and IL-10 [J].
Bergeron, A ;
Soler, P ;
Kambouchner, M ;
Loiseau, P ;
Milleron, B ;
Valeyre, D ;
Hance, AJ ;
Tazi, A .
EUROPEAN RESPIRATORY JOURNAL, 2003, 22 (01) :69-76